January 30, 2018
For CTE Awareness Day, we highlight our support of diagnostic tools and treatments for this disease.
December 28, 2017
Learn what a biomarker is, why they matter to the ADDF, which biomarkers we have, and which ones we need.
September 27, 2016
Protein tracer shows distinctive pattern of brain protein deposition specific to this disease and typically confirmed after death
July 7, 2016
The ADDF awarded five new grants in May and June 2016, totaling nearly $1.5 million.
May 10, 2016
The ADDF has awarded 10 new grants to researchers developing drugs for neurodegenerative diseases and biomarkers to detect their onset and progression.
July 28, 2014
Our neuroscientists share highlights from their favorite sessions at the 2014 Alzheimer’s Association International Conference (AAIC) in Copenhagen, Denmark.
May 20, 2014
Healthcare professionals rarely screen patients—even those with many risk factors—for cognitive issues or dementia.
August 19, 2013
I recently saw a patient who was afraid he had Alzheimer's disease. A new scan made it easy to give him an accurate diagnosis. So why can't most patients use it?
February 5, 2013
Howard Fillit, MD and George Vradenburg of USAgainstAlzheimer's issued a joint statement, responding to MEDCAC's opinion to not support Medicare reimbursement for PET amyloid imaging scans.
April 6, 2012
The FDA has approved Amyvid™, the first diagnostic test for Alzheimer's disease, for which the ADDF provided critical seed funding.